Pharmaceutical Industry Information Portal

HomePharmaceutical Investing News

Pharmaceutical Investing News

Hello Heart raises $70 million to support growth in customer demand

Hello Heart, the only digital therapeutic that focuses on heart health, announced that it has raised $70 million in Series D financing to support...

Antibe Therapeutics, a $6.5 million strategic sale to a subsidiary of Citagenix

Antibe Therapeutics Inc., a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation announced to sell its...

Australian Biotron’s share price rose 38% due to COVID-19 study results

Shares in the small-cap biotech jumped 37.5% to 9.9 cents each after reporting positive COVID-19 animal trial results today. Biotron Limited is engaged in the...

Bristol Myers Squibb sales grew in Q1 due to growth in line products

Pharmaceutical company, drug maker Bristol Myers Squibb on Friday posted slightly higher-than-expected first-quarter earnings thanks to increased sales of its blood-thinning drug Eliquis and...

AbbVie revenues exceeded forecasts, but fell short of expectations

AbbVie reported on Friday first quarter earnings that beat analysts' forecasts and revenue that fell short of expectations. AbbVie announced earnings per share of $3.16...

Novo Nordisk raises 2022 outlook after strong quarter, shares up

Novo Nordisk targets higher sales and operating profit for the year on the back of projected profit growth in the first quarter thanks to...
spot_img

Expert Articles

spot_img